Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models.
Hanahan
D
D
Hormone Research Institute, University of California, San Francisco 94143-0534, USA.
Christofori
G
G
Naik
P
P
Arbeit
J
J
D000818:Animals; D004341:Drug Evaluation; D004730:Endothelium, Vascular / Q000378:metabolism; D005260:Female; D005346:Fibroblast Growth Factors / Q000378:metabolism; D006133:Growth Substances / Q000378:metabolism; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D008954:Models, Biological; D009374:Neoplasms, Experimental / Q000098:blood supply*; D009389:Neovascularization, Pathologic / Q000503:physiopathology*; D009857:Oncogenes / Q000502:physiology
D006133:Growth Substances; D005346:Fibroblast Growth Factors